The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CD3 and CD20 immune cell densities in primary tumors, lymph node metastasis, and recurrent disease samples of head and neck squamous cell carcinoma.
 
Simon Laban
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
 
Romain Remark
Employment - Innate Pharma
Stock and Other Ownership Interests - Innate Pharma
Patents, Royalties, Other Intellectual Property - Mount Sinai School of Medicine
 
Christian Idel
Honoraria - Merck Sharp & Dohme
 
Julika Ribbat-Idel
No Relationships to Disclose
 
Andreas Schröck
No Relationships to Disclose
 
Jasmin Ezić
No Relationships to Disclose
 
Johannes Döscher
Consulting or Advisory Role - Merck Serono (Inst); Merck Sharp & Dohme (Inst)
 
Marie-Nicole Theodoraki
No Relationships to Disclose
 
Rosemarie Krupar
No Relationships to Disclose
 
Andrew G. Sikora
Consulting or Advisory Role - Tessa Therapeutics
Research Funding - Heat Biologics (Inst)
Patents, Royalties, Other Intellectual Property - Patents filed (Inst)
 
Glen Kristiansen
No Relationships to Disclose
 
Friedrich Bootz
No Relationships to Disclose
 
Guray Akturk
No Relationships to Disclose
 
Thomas Jens Ettrich
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi/Aventis
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen; Ipsen
 
Hazem Edmond El-Osta
No Relationships to Disclose
 
Patrick J Schuler
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Cornelia Brunner
No Relationships to Disclose
 
Thomas K Hoffmann
Honoraria - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst)
 
Sven Perner
No Relationships to Disclose
 
Sacha Gnjatic
Consulting or Advisory Role - B4CC; Bristol-Myers Squibb; Merck; Neon Therapeutics; OncoMed; Third Rock Ventures
Research Funding - Agenus; Immune Design; Janssen; Pfizer; Regeneron; Takeda
Patents, Royalties, Other Intellectual Property - Patent on Multiplex Immunohistochemistry with Chromogen Staining on a Single Slide (MICSSS); Patents related to immune composition of NY-ESO-1 and peptides.